Citigroup Inc Sensus Healthcare, Inc. Transaction History

Citigroup Inc

$217 Billion
Q3 2025

A detailed history of Citigroup Inc transactions in Sensus Healthcare, Inc. stock. As of the latest transaction made, Citigroup Inc holds 25 shares of SRTS stock, worth $108. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Holding current value

$108

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2025 Nov 10, 2025	BUY	$3.09 - $5.65 $77 - $141	25 New	25 $0
Q3 2022 Nov 10, 2022	BUY	$7.64 - $14.97 $1,757 - $3,443	230 New	230 $3,000

Others Institutions Holding SRTS

# of Institutions

Shares Held

4.22M

Call Options Held

18.7K

Put Options Held

28.7K

Vanguard Group Inc Valley Forge, PA

729K
Shares

$3.15 Million
0.0% of portfolio
Pacific Ridge Capital Partners, LLC Lake Oswego, OR

573K
Shares

$2.48 Million
0.44% of portfolio
Dimensional Fund Advisors LP Austin, TX

569K
Shares

$2.46 Million
0.0% of portfolio
Divisadero Street Capital Management, LP Miami, FL

453K
Shares

$1.96 Million
0.09% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

261K
Shares

$1.13 Million
0.0% of portfolio

View Full List

About Sensus Healthcare, Inc.

Ticker SRTS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 16,556,000
Market Cap $71.5M
Description
Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provide...

More about SRTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account